Article
JAK2 V617F gene mutation in the laboratory work-up of myeloproliferative disorders: experience of a major referral center in Lebanon.
Genetic testing and molecular biomarkers - 1 Apr 2011
Mahfouz Rami A R, Hoteit Rouba, Salem Ziad, Bazarbachi Ali, Mugharbel Anas, Farhat Fadi, Ziyadeh Azzam, Ibrahim Ahmad, Taher Ali
Abstract excerpt
AIMS: JAK2 V617F mutation is gaining more acceptance in laboratory testing as part of the differential diagnosis work-up of myeloproliferative disorders (MPD). This report is the first of its kind from Lebanon that analyzes the distribution of this mutation among a series of referred cases to a major tertiary referral center. METHODS: Real-time polymerase chain reaction using JAK2 V617F MutaScreen assay (IPSOGEN...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.